Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDCD1 | Q15116 | 4/20 | 0.34 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.34 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | PPARD | Q03181 | 1/20 | 0.32 |
| ▸ | PTGDR2 | Q9Y5Y4 | 3/20 | 0.32 |
| ▸ | PTGER1 | P34995 | 4/20 | 0.31 |
| ▸ | ANO1 | Q5XXA6 | 2/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 0.31 |
| ▸ | CPT1A | P50416 | 1/20 | 0.31 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31269222 | 0.97 | CD274 (0.35) | PDCD1CD274PIK3CDPTGDR2PTGER1 | |
| SCHEMBL31269043 | 0.95 | PIK3CD (0.35) | PDCD1CD274PIK3CDPTGER1CNR1 | |
| SCHEMBL31269105 | 0.95 | PIK3CD (0.33) | PDCD1CD274PIK3CDPPARDPTGDR2 | |
| SCHEMBL30983441 | 0.92 | PDCD1 (0.36) | PDCD1CD274PIK3CDPTGDR2PTGER1 | |
| SCHEMBL31268752 | 0.90 | PIK3CD (0.32) | PIK3CDPTGDR2CNR1 | |
| SCHEMBL30984001 | 0.90 | ADORA3 (0.35) | PDCD1CD274PIK3CDCNR1ADORA3 | |
| SCHEMBL31269188 | 0.90 | CD274 (0.34) | PDCD1CD274PIK3CDANO1CNR1 | |
| SCHEMBL31268913 | 0.89 | CNR1 (0.34) | PDCD1CD274PIK3CDPPARDPTGER1 | |
| SCHEMBL31269134 | 0.89 | PLA2G2A (0.35) | PIK3CDPPARGPPARDPTGDR2CNR1 | |
| SCHEMBL31268870 | 0.88 | PDCD1 (0.34) | PDCD1CD274PIK3CDPTGER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024201368-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | ASTRAZENECA AB (SE) | 2024-10-03 | — | — | WO | disclosed |